Cargando…

ORAL DRUG THERAPY – IMPROVING SURVIVAL IN MALIGNANT MELANOMA

Detalles Bibliográficos
Autores principales: O’Neill, CH, Carser, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Ulster Medical Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849965/
https://www.ncbi.nlm.nih.gov/pubmed/29588565
_version_ 1783306144784056320
author O’Neill, CH
Carser, J
author_facet O’Neill, CH
Carser, J
author_sort O’Neill, CH
collection PubMed
description
format Online
Article
Text
id pubmed-5849965
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Ulster Medical Society
record_format MEDLINE/PubMed
spelling pubmed-58499652018-03-27 ORAL DRUG THERAPY – IMPROVING SURVIVAL IN MALIGNANT MELANOMA O’Neill, CH Carser, J Ulster Med J Game Changers The Ulster Medical Society 2018-01-31 2018-01 /pmc/articles/PMC5849965/ /pubmed/29588565 Text en Copyright © 2018 Ulster Medical Society http://creativecommons.org/licenses/by-nc-nd/4.0/ The Ulster Medical Society grants to all users on the basis of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Licence the right to alter or build upon the work non-commercially, as long as the author is credited and the new creation is licensed under identical terms.
spellingShingle Game Changers
O’Neill, CH
Carser, J
ORAL DRUG THERAPY – IMPROVING SURVIVAL IN MALIGNANT MELANOMA
title ORAL DRUG THERAPY – IMPROVING SURVIVAL IN MALIGNANT MELANOMA
title_full ORAL DRUG THERAPY – IMPROVING SURVIVAL IN MALIGNANT MELANOMA
title_fullStr ORAL DRUG THERAPY – IMPROVING SURVIVAL IN MALIGNANT MELANOMA
title_full_unstemmed ORAL DRUG THERAPY – IMPROVING SURVIVAL IN MALIGNANT MELANOMA
title_short ORAL DRUG THERAPY – IMPROVING SURVIVAL IN MALIGNANT MELANOMA
title_sort oral drug therapy – improving survival in malignant melanoma
topic Game Changers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849965/
https://www.ncbi.nlm.nih.gov/pubmed/29588565
work_keys_str_mv AT oneillch oraldrugtherapyimprovingsurvivalinmalignantmelanoma
AT carserj oraldrugtherapyimprovingsurvivalinmalignantmelanoma